Morepen Laboratories Limited (MOREPENLAB.NS) NSE

45.79

-0.72(-1.55%)

Updated at June 02 03:30PM

Currency In INR

Valuation

Market Cap20.4B
Enterprise Value21.79B
P/E Ratio27.14
PEG Ratio-1.27
Price/Sales Ratio1.39
Price/Book Ratio2.07
Enterprise/Revenue1.47
Enterprise/EBITDA15.33

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.05
Operating Margin0.05

Management Effectiveness

Return On Assets0.05
Return On Equity0.08

Income Statement

Revenue18.06B
Revenue/Share32.11
Gross Profit6.82B
EBITDA1.73B
Net Income948.77M
Diluted EPS1.73

Balance Sheet

Total Cash916.99M
Total Cash/Share1.63
Total Debt2.08B
Total Debt/Equity0.17
Current Ratio2.37
Book Value Per Share22.18

Price History

52-Week Change-29.4
52-Week High70.5
52-Week Low33.05
Moving Average 50 Days41.32
Moving Average 200 Days43.02

Statistics

Average Volume4.2M
Shares Outstanding547.95M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.2
Trailing Annual Dividend Yield0.44
Payout Ratio0.11
Last Split Factor5:1
Last Split DateNovember 07, 2000